orserdu
stemline therapeutics b.v. - elacestrant - neoplasmy prsů - endokrinní terapie - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
bonaxon 0,5mg tvrdá tobolka
egis pharmaceuticals plc, budapešť array - 19410 fingolimod-hydrochlorid - tvrdá tobolka - 0,5mg - fingolimod
cetalgen 500mg/200mg potahovaná tableta
glenmark pharmaceuticals s.r.o., praha array - 1593 ibuprofen; 1064 paracetamol - potahovaná tableta - 500mg/200mg - paracetamol, kombinace kromĚ psycholeptik
efigalo 0,5mg tvrdá tobolka
krka, d.d., novo mesto, novo mesto array - 19410 fingolimod-hydrochlorid - tvrdá tobolka - 0,5mg - fingolimod
fimodigo 0,5mg tvrdá tobolka
vipharm s.a., ożarów mazowiecki array - 19410 fingolimod-hydrochlorid - tvrdá tobolka - 0,5mg - fingolimod
fingolimod fresenius kabi 0,5mg tvrdá tobolka
fresenius kabi s.r.o., praha array - 19410 fingolimod-hydrochlorid - tvrdá tobolka - 0,5mg - fingolimod
fingolimod glenmark 0,5mg tvrdá tobolka
glenmark pharmaceuticals s.r.o., praha array - 19410 fingolimod-hydrochlorid - tvrdá tobolka - 0,5mg - fingolimod
fingolimod medochemie 0,5mg tvrdá tobolka
medochemie ltd., limassol array - 19410 fingolimod-hydrochlorid - tvrdá tobolka - 0,5mg - fingolimod
fingolimod msn 0,5mg tvrdá tobolka
msn labs europe limited, paola array - 19410 fingolimod-hydrochlorid - tvrdá tobolka - 0,5mg - fingolimod
fingolimod +pharma 0,5mg tvrdá tobolka
+pharma arzneimittel gmbh, graz array - 19410 fingolimod-hydrochlorid - tvrdá tobolka - 0,5mg - fingolimod